Pedro Perez on Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Even with major advances in treatment, outcomes in deep vein thrombosis (DVT) still depend heavily on early decisions.
Many preventable complications—such as pulmonary embolism, bleeding, recurrence, and long-term leg symptoms—don’t happen because we lack treatment options.
They happen when the early steps aren’t clear or consistent.
A few principles that still matter:
• Assess risk before jumping to testing
• Use blood tests thoughtfully, not automatically
• Imaging should be targeted, not excessive
• Treatment plans should be intentional and reassessed
• The first few months after diagnosis are critical
When DVT is approached in a structured, step-by-step way, outcomes improve and unnecessary interventions can often be avoided.
Clear decision-making early on remains one of the most powerful tools in managing DVT—now and in the years ahead.”
Stay updated with Hemostasis Today.
-
Mar 12, 2026, 16:36Giordano Botta: From the ‘Power of Zero’ to a Precise Understanding of Cardiovascular Risk
-
Mar 12, 2026, 16:31Katie Baca-Motes: Incorporating Menstrual Cycle and Hormonal Rhythms Into Clinical Research
-
Mar 12, 2026, 16:22Augustina Isioma Ikusemoro: Quality Indicators in Processed Blood Components
-
Mar 12, 2026, 16:20Aryabhatta Sadhu: The Full Spectrum of Transplant Immunology and Clinical Care
-
Mar 12, 2026, 16:17Megan Adediran: Building Pathways to Sustainable Care for People With Bleeding Disorders in Nigeria
-
Mar 12, 2026, 16:09Rob Mac Sweeney: Hemodynamic Failure During Sepsis
-
Mar 12, 2026, 16:06Haroun Gajraj: Shortwave Diathermy for Facial Spider Veins
-
Mar 12, 2026, 12:05Kent H: The Lymphatic System – The Unsung Hero of Detox
-
Mar 12, 2026, 11:55Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory